Trametinib - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Trametinib

Brand Name:

Mekinist

Strength:

0.5 mg

HCPCS:

NA

SEER*Rx Category:

Chemotherapy

Major Drug Class:

MEK Inhibitor

Minor Drug Class:

BRAF

Oral (Y/N):

Yes

FDA Approval Year:

2013

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use